Italia markets open in 6 hours 51 minutes

Amgen Inc. (AMGN)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
225,99-0,88 (-0,39%)
Alla chiusura: 04:00PM EDT
227,55 +1,56 (+0,69%)
Dopo ore: 07:27PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente226,87
Aperto226,97
Denaro225,51 x 800
Lettera227,75 x 800
Min-Max giorno225,02 - 229,96
Intervallo di 52 settimane198,64 - 258,45
Volume1.939.235
Media Volume2.632.403
Capitalizzazione120,889B
Beta (5 anni mensile)0,56
Rapporto PE (ttm)19,22
EPS (ttm)11,76
Prossima data utili31 ott 2022 - 04 nov 2022
Rendimento e dividendo (forward)7,76 (3,42%)
Data ex dividendo17 ago 2022
Stima target 1A253,12
  • GlobeNewswire

    BriaCell Appoints Renowned Pharmaceutical Veteran Jane Gross, Ph.D. to its Board of Directors

    NEW YORK and VANCOUVER, British Columbia, Nov. 02, 2021 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers, is pleased to welcome the appointment of Jane Gross, Ph.D. to its Board of Directors. Dr. Jane Gross is a highly experienced biotech executive with over 30 years in leading research and development teams f